Once absorbed, anticancer drugs are distributed throughout the body via the bloodstream. The distribution is influenced by the drug's lipophilicity, molecular size, and binding to plasma proteins. Drugs must also cross biological barriers to reach the tumor site, and in some cases, the blood-brain barrier can limit drug distribution to brain tumors.
